Understanding Your Cholesterol Report: Complete Guide

Quick answer

Your cholesterol report has four key numbers: LDL (the artery-clogging type to lower), HDL (the protective type to raise), triglycerides and non-HDL, with the total-to-HDL ratio giving useful perspective. The core takeaway: LDL is the main treatment target, and your 10-year cardiovascular risk, not the total cholesterol number alone, decides whether statin treatment is worthwhile.

The four numbers and what they mean

1. Total Cholesterol: the headline number

Total cholesterol is the sum of all cholesterol types in your blood. Below 200 mg/dL is desirable. But total cholesterol alone is a poor predictor of heart risk: a person with high HDL (protective) may have a high total cholesterol but low actual risk. Always look at the individual components.

2. LDL: the number that matters most

LDL (Low-Density Lipoprotein) is the primary driver of atherosclerosis. It deposits in artery walls. The lower your LDL, the lower your heart attack risk. For healthy adults: below 100 mg/dL is optimal. For people with diabetes, high blood pressure or previous heart attack: aim below 70 mg/dL. Statins primarily work by lowering LDL.

3. HDL: higher is better

HDL (High-Density Lipoprotein) is the only cholesterol you want HIGH. It removes excess cholesterol from artery walls. Men need above 40 mg/dL, women above 50 mg/dL. Above 60 mg/dL is protective against heart disease. Raised by: exercise, weight loss, quitting smoking, moderate alcohol (in those who already drink), and niacin supplements.

4. Triglycerides: the sugar-fat connection

Triglycerides are fats stored from excess calories, especially from sugar, refined carbs and alcohol. Normal is below 150 mg/dL. Above 500 mg/dL is dangerous (pancreatitis risk). The best way to lower triglycerides is to cut sugar and refined carbohydrates: more effective than cutting fat.

The ratio that matters: Total Cholesterol ÷ HDL

Ratio	Risk Level
Below 3.5	Low risk
3.5 – 5.0	Moderate risk
Above 5.0	High risk

Key points

LDL drives artery disease: lower is better; below 100 mg/dL is optimal for healthy adults.
HDL is protective: above 40 (men) and 50 (women) mg/dL; above 60 is ideal.
Triglycerides and non-HDL complete the picture; total alone is a poor guide.
10-year risk, not total cholesterol, decides on statins.

How often should you check cholesterol?

Adults 20–39 with no risk factors: every 4–6 years
Adults 40+ or with diabetes/hypertension/obesity: every 1–2 years
People on statins: every 3–6 months until stable, then yearly
Anyone with a family history of early heart disease: start screening at age 20

Foods that lower LDL cholesterol

Oats and oat bran: soluble fibre binds cholesterol
Beans and lentils: soluble fibre + plant protein replaces meat
Nuts (walnuts, almonds): unsaturated fats lower LDL
Fatty fish: omega-3 lowers triglycerides
Fruits rich in pectin: apples, citrus, strawberries
Olive oil: replaces saturated fats in cooking

LDL, HDL, triglycerides, and non-HDL, what each number means

A standard lipid panel measures four values, and each provides different information about cardiovascular risk:

LDL cholesterol (low-density lipoprotein): The primary target of cholesterol-lowering therapy. LDL particles can penetrate arterial walls and become oxidised, initiating atherosclerosis (plaque formation). The lower the LDL, the lower the risk. NICE guidelines target LDL below 2.0 mmol/L for people with established cardiovascular disease, or below 3.0 mmol/L for primary prevention.
HDL cholesterol (high-density lipoprotein): Often called "good cholesterol" because HDL particles transport cholesterol from arterial walls back to the liver for disposal (reverse cholesterol transport). A low HDL (below 1.0 mmol/L in men, below 1.2 mmol/L in women) is an independent risk factor for heart disease. Exercise, stopping smoking, and moderate alcohol reduction are the main lifestyle strategies for raising HDL.
Triglycerides: Fats carried in the blood after meals and released from fat stores. Elevated fasting triglycerides (above 1.7 mmol/L) indicate insulin resistance, metabolic syndrome, type 2 diabetes risk, and contribute to cardiovascular risk independently of LDL. Very high triglycerides (above 10 mmol/L) risk acute pancreatitis and require urgent treatment with fibrates and strict dietary fat restriction.
Non-HDL cholesterol: Total cholesterol minus HDL. This captures LDL plus VLDL (very low-density lipoprotein), all atherogenic particles together. Non-HDL is more accurate than LDL alone when triglycerides are elevated (which distorts the standard LDL calculation). Target: below 2.6 mmol/L in high-risk patients.

How statins work, and what the evidence actually shows

Statins (atorvastatin, rosuvastatin, simvastatin, pravastatin) work by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis in the liver. Reduced liver cholesterol production causes liver cells to upregulate their LDL receptors, pulling more LDL out of the bloodstream. The result: LDL falls by 30–55% depending on dose and statin potency.

The evidence base for statins is one of the strongest in medicine: meta-analyses of over 170,000 patients demonstrate that each 1 mmol/L reduction in LDL reduces major cardiovascular events (heart attack, stroke, cardiovascular death) by approximately 22%, a risk reduction that compounds with treatment duration and is consistent regardless of baseline cholesterol level.²

Common concerns addressed by evidence:

Muscle aches (myalgia): Occur in 5–10% of patients in observational studies, but in randomised placebo-controlled trials the rate is only marginally higher than placebo, suggesting a significant nocebo effect (expecting side effects causes them). True statin myopathy with elevated CK is uncommon; rhabdomyolysis (muscle breakdown with kidney injury) is rare (approximately 1 in 10,000 patient-years).
Diabetes risk: Statins mildly increase the risk of new-onset type 2 diabetes (approximately 1 extra case per 200 patients treated over 5 years). This is far outweighed by cardiovascular benefit in high-risk patients, but suggests annual HbA1c monitoring in those with pre-diabetes.
Liver toxicity: Mild transaminase rises are common but rarely progress. Routine LFT monitoring is no longer recommended by NICE in patients on statins.

10-year cardiovascular risk and who benefits from treatment

Cholesterol numbers alone do not determine who should be treated. UK clinicians use QRISK3 (an online risk calculator) to estimate the 10-year probability of a heart attack or stroke based on age, sex, cholesterol, blood pressure, smoking status, diabetes, family history, ethnicity, and other factors. NICE recommends offering statin therapy to anyone with a 10-year cardiovascular risk of 10% or more (using atorvastatin 20 mg, which is generic and low cost). People with established cardiovascular disease (previous heart attack, stroke, or angina) are treated regardless of their baseline cholesterol, the benefit is proven even when cholesterol is "normal".³

Your next steps for your cholesterol report

Read all four numbers, not just the total
Total cholesterol below 200 mg/dL is desirable, but total alone is a poor predictor — high HDL can inflate it while risk stays low. Read LDL, HDL and triglycerides individually.
Calculate the ratio and the 10-year risk
Total ÷ HDL below 3.5 is low risk, 3.5–5.0 moderate, above 5.0 high. Then ask for a 10-year risk score (QRISK3, ASCVD, SCORE2) — that score, not total cholesterol, decides whether a statin is worthwhile.
Retest on schedule, not randomly
Every 4–6 years at 20–39 with no risk factors, every 1–2 years at 40+ or with risk factors, every 3–6 months until stable on a statin. Calendar retesting makes results comparable.
Move LDL with the proven levers
Soluble fibre (oats, beans), nuts, fatty fish, olive oil and cutting sugar and refined carbs move the numbers that matter. Triglycerides respond especially well to cutting sugar and alcohol.
Discuss statins on risk, not fear
The evidence base is one of medicine’s strongest: each 1 mmol/L LDL reduction cuts major cardiovascular events by about 22%. Muscle aches in trials run only marginally above placebo, and the small diabetes risk is far outweighed by cardiovascular benefit in high-risk patients.

The four cholesterol numbers at a glance

Your lipid report has four key numbers plus non-HDL. This table compiles targets; the article explains the ratio, statins and risk assessment.

Number	Target	What it means
Total cholesterol	<200 mg/dL desirable	Sum of all cholesterol; a poor risk predictor on its own
LDL	<100 mg/dL optimal (healthy adults)	Primary driver of atherosclerosis; the main treatment target
HDL	>40 men, >50 women mg/dL; >60 protective	The one you want high; clears cholesterol from artery walls
Triglycerides	<150 mg/dL; >500 dangerous (pancreatitis risk)	Driven by sugar, refined carbs and alcohol; signals insulin resistance
Non-HDL cholesterol	Total minus HDL	Captures all atherogenic particles; more accurate than LDL when triglycerides are high
Total ÷ HDL ratio	<3.5 low risk; >5.0 high risk	A single ratio summarising the balance

Practical notes

Check whether you need to fast. A 9–12 hour fast is still commonly requested because triglycerides — and therefore calculated LDL — read higher after eating, though many labs now offer direct LDL measurement without fasting. Ask the lab which method they use, avoid alcohol for 24 hours before the test, and don't crash-diet in the days beforehand: eat your usual diet so the result reflects your real life.

Ask which number your doctor is actually watching. Total cholesterol alone is a poor guide — high protective HDL can inflate it — so the conversation usually centres on LDL, non-HDL cholesterol or triglycerides, read alongside your blood pressure, age, smoking and family history. Ask whether a 10-year risk estimate was calculated and what went into it.

Read the report as a risk picture, not a pass-or-fail exam. Two people with the same LDL can have very different treatment thresholds because risk depends on the whole profile. Small day-to-day variation is normal, so one borderline reading is usually confirmed with a repeat before any decision.

Give lifestyle changes time to show. Diet, activity and weight changes typically need about three months before a recheck can fairly reflect them, since that is roughly how long cholesterol patterns take to shift. Ask your doctor when to retest rather than checking every few weeks.

In India

A lipid profile at a large Indian laboratory typically costs around ₹400–₹1,000 — though prices vary by city and lab — and it is bundled into nearly every preventive health package.

Most large labs are NABL-accredited and offer home sample collection in major cities; confirm fasting instructions when you book, since they differ by lab method. The reference range printed on your own report is the one that counts for your result.

Frequently Asked Questions

What do the four cholesterol numbers mean?

Total cholesterol is the sum of all cholesterol types — below 200 mg/dL is desirable, but it is a poor risk predictor alone because high protective HDL can inflate it. LDL is the primary driver of atherosclerosis (below 100 mg/dL is optimal for healthy adults). HDL is the one you want high (above 40 in men, 50 in women) because it clears cholesterol from artery walls. Triglycerides below 150 mg/dL is normal; above 500 is dangerous because of pancreatitis risk.

What are LDL, HDL, triglycerides and non-HDL?

LDL particles penetrate arterial walls and initiate plaque — it is the primary target of cholesterol-lowering therapy. HDL transports cholesterol from artery walls back to the liver for disposal. Fasting triglycerides above 1.7 mmol/L indicate insulin resistance or metabolic syndrome. Non-HDL (total minus HDL) captures LDL plus VLDL together and is more accurate than LDL alone when triglycerides are high.

How do statins work, and what does the evidence show?

Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in liver cholesterol synthesis; the liver then upregulates LDL receptors and pulls more LDL from the blood. Meta-analyses of over 170,000 patients show each 1 mmol/L LDL reduction cuts major cardiovascular events by about 22%. In placebo-controlled trials, muscle aches run only marginally above placebo, and routine LFT monitoring is no longer recommended by NICE.

Who benefits from cholesterol treatment based on 10-year risk?

Cholesterol numbers alone don't decide treatment. Clinicians use QRISK3 and similar calculators to estimate 10-year heart attack and stroke probability from age, sex, cholesterol, blood pressure, smoking, diabetes and family history. A score above the guideline threshold — 10% on QRISK3 in the UK — is what makes statin therapy worthwhile, not the total cholesterol figure.

Do I need to fast before a cholesterol test?

Often yes, but not always. A 9–12 hour fast is commonly requested because eating raises triglycerides and affects calculated LDL; however, many labs now measure LDL directly and accept non-fasting samples. Ask your lab which method they use when you book — and avoid alcohol for 24 hours before either way.

My total cholesterol is high but my HDL is high too — is that still a problem?

It depends on the rest of the picture. Total cholesterol is the sum of all fractions, so high HDL can inflate it without raising risk much — which is exactly why doctors focus on LDL and non-HDL cholesterol instead. Bring the full report to your doctor rather than judging by the total alone.

How soon after changing my diet should I recheck my cholesterol?

Give it about three months. Cholesterol patterns shift slowly, so retesting after a few weeks of dietary change usually just measures noise. Your doctor will suggest a sensible recheck interval — ask what it is and what change they would consider meaningful.

My triglycerides were high — could it be because I ate before the test?

Quite possibly. Triglycerides are the fraction most sensitive to a recent meal, and a non-fasting sample can read substantially higher than a fasting one. Alcohol the night before raises them too. If the test wasn't done fasting, ask your doctor whether a fasting repeat would be more informative before drawing conclusions.

References

Sources cited on this page. PubMed links open the original abstract.

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285–e350. PMID 30423393 · doi:10.1016/j.jacc.2018.11.003
Grundy SM, Stone NJ, Bailey AL, et al. "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." Circulation. 2019;139(25):e1082–e1143. PMID 30586774 · doi:10.1161/CIR.0000000000000625
Hippisley-Cox J, Coupland C, Brindle P. "Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study." BMJ. 2017;357:j2099. PMID 28536104 · doi:10.1136/bmj.j2099

Medical Disclaimer: This page is for general educational purposes only. It does not constitute medical advice. Always consult a qualified doctor before making any health decisions.